Global MRI Compatible Biopsy Device Market Size By Type (Biopsy Needles, Biopsy Guns), By Application (Hospitals, Diagnostic Centers), By Region, And Segment Forecasts, 2023 to 2032

The Global MRI Compatible Biopsy Device Market was valued at USD 0.92 billion in 2023 and is projected to reach USD 1.76 billion by 2031, growing at a CAGR of 8.4% during the forecast period from 2023 to 2031. This market's expansion is driven by the increasing demand for minimally invasive procedures, rising adoption of MRI-guided biopsies for precise cancer diagnosis, and growing prevalence of breast and prostate cancers. MRI-compatible biopsy devices provide enhanced imaging clarity and tissue sampling accuracy, particularly in sensitive areas where conventional biopsies pose limitations.

Drivers:

1. Rising Incidence of Cancer Worldwide:

With an increasing number of cancer cases globally, particularly breast and prostate cancers, the need for early and precise diagnosis has surged. MRI-compatible biopsy devices are crucial for accurate tissue sampling, making them indispensable in modern oncology.

2. Advancements in Imaging Technology:

Integration of real-time imaging with biopsy procedures has significantly improved diagnostic precision. Technological advancements in MRI systems and compatibility with minimally invasive tools are enhancing procedure outcomes.

3. Preference for Minimally Invasive Procedures:

Patients and healthcare providers are increasingly opting for procedures with minimal recovery time, reduced risk, and better accuracy. MRI-compatible biopsy devices meet these requirements, especially for high-risk and delicate anatomical areas.

Restraints:

1. High Equipment and Procedure Costs:

The cost of MRI-compatible biopsy devices and MRI scans themselves remain a challenge, particularly in developing regions with limited healthcare budgets.

2. Limited Accessibility in Emerging Markets:

Access to MRI-guided biopsy procedures is limited in lower-income countries due to infrastructure constraints and lack of trained personnel, which can hinder global market penetration.

Opportunity:

1. Expanding Applications Beyond Oncology:

The application of MRI-compatible biopsy devices is expanding into neurology, musculoskeletal conditions, and other soft tissue pathologies, presenting lucrative opportunities for manufacturers.

2. Strategic Collaborations and Product Launches:

Partnerships between medical device companies and healthcare institutions are enabling the development of next-generation biopsy tools with enhanced MRI compatibility and precision features.

Market by System Type Insights:

Based on system type, the Vacuum-Assisted Biopsy (VAB) Devices segment dominated the market in 2023. VAB systems allow for larger and more accurate sample collection under MRI guidance, making them the preferred choice in diagnosing complex lesions. Meanwhile, Core Needle Biopsy Devices are also experiencing steady growth due to their cost-effectiveness and improved precision in recent designs.

Market by End-Use Insights:

In terms of end use, the Hospitals segment accounted for the largest market share in 2023, driven by the increasing installation of advanced imaging infrastructure and availability of specialized personnel. Diagnostic Imaging Centers are expected to exhibit the highest growth rate due to the rising preference for outpatient diagnostic services and lower procedural costs compared to hospital settings.

Market by Regional Insights:

Geographically, North America led the market in 2023, supported by a well-established healthcare system, high awareness levels, and early adoption of advanced diagnostic technologies. Europe followed closely, particularly due to increasing breast cancer screening programs. Asia-Pacific is projected to be the fastest-growing region during the forecast period, driven by improving healthcare infrastructure, growing patient population, and rising government investments in cancer diagnostics.

Competitive Scenario:

Leading companies in the Global MRI Compatible Biopsy Device Market include BD (Becton, Dickinson and Company), Siemens Healthineers, Medtronic, Argon Medical Devices, INRAD Inc., IZI Medical, and Stryker Corporation. These players are emphasizing innovations such as integration of robotics and AI in MRI-guided biopsies, expanding product portfolios, and entering strategic collaborations with imaging centers and hospitals.

Scope of Work – Global MRI Compatible Biopsy Device Market

Report Metric Details

Market Size (2023) USD 0.92 Billion

Projected Market Size (2031) USD 1.76 Billion

CAGR (2023–2031) 8.4%

Key Segments by System Type Vacuum-Assisted Biopsy Devices, Core Needle Biopsy Devices

Key Segments by End Use Hospitals, Diagnostic Imaging Centers

Leading Region North America

Key Players BD, Medtronic, Siemens Healthineers, Argon Medical Devices, INRAD Inc., Stryker

Key Market Developments:

2023: BD launched a new MRI-compatible VAB system with improved ergonomics and enhanced imaging integration.

2024: Siemens Healthineers introduced AI-powered biopsy software aimed at improving precision and workflow in MRI-guided procedures.

2025: Medtronic expanded its diagnostic product line with a hybrid MRI/ultrasound-guided biopsy device targeting multi-modal diagnostic centers.

FAQs:

1. What is the current market size of the Global MRI Compatible Biopsy Device Market?

The market was valued at USD 0.92 billion in 2023.

2. What is the major growth driver of the Global MRI Compatible Biopsy Device Market?

The key driver is the rising incidence of cancer and the growing preference for minimally invasive and highly accurate diagnostic procedures.

3. Which is the largest region during the forecast period in the Global MRI Compatible Biopsy Device Market?

North America is projected to remain the largest region, supported by robust infrastructure and high adoption rates.

4. Which segment accounted for the largest market share in the Global MRI Compatible Biopsy Device Market?

The Vacuum-Assisted Biopsy Devices segment led the market in 2023.

5. Who are the key market players in the Global MRI Compatible Biopsy Device Market?

Key players include BD, Medtronic, Siemens Healthineers, Argon Medical Devices, INRAD Inc., and Stryker Corporation.